Related by context. All words. (Click for frequent words.) 63 MAXY alpha 63 XP# XP# 62 CEFF financings subject 62 recombinant PSMA vaccine 61 PDE# inhibitors 61 albiglutide 61 candidate XP# 61 cancer indications bafetinib 61 mecarbil 61 stage antibody MT# 60 solid tumors ZYBRESTAT 60 stage hypoxia activated 60 including eniluracil ADH 60 MAXY VII 60 please visit http:/www.atherogenics.com 60 MAGE A3 ASCI 60 developing ostarine selective 60 Telik logo TELINTRA 60 candidate CRLX# 60 Submits Biologics License Application 60 AAG geldanamycin analog 59 non nucleoside HCV 59 PORxin TM platforms 59 CYT# potent vascular disrupting 59 torsemide ER 59 Xcytrin R 59 nalbuphine ER 59 Submits NDA 59 Empatic ™ 59 elotuzumab 59 Completes Patient Enrollment 59 SILENOR 59 opioid induced bowel dysfunction 59 ALN PCS 59 evaluating mipomersen 59 oxymorphone ER 59 Prodarsan R 59 interferon gamma 1b 58 CORLUX CORT # 58 Submits Response 58 developing ACAPODENE 58 Captisol ® 58 Nanobody R 58 PrimeSuite integrates practice 58 data management Clintrial 58 Testosterone MDTS ® 58 inflammatory autoimmune diseases 58 XL# anticancer compounds 58 adecatumumab MT# 58 technology visit http:/www.genmab.com 58 Solazed TM 58 website http:/www.depomed.com 58 markets HP Acthar 58 Rotarix ® 58 visit www.targanta.com 58 includes TOLAMBA TM 58 approved incretin mimetic 58 oral methylnaltrexone 58 management biostatistical analysis 58 ularitide 58 Entereg R 58 RAPTIVA R 58 5 lipoxygenase inhibitor 58 novel trazodone formulation 58 opioid bowel dysfunction 58 serine protease inhibitor CU# 58 TRIOLEX ™ 58 oral prodrug 58 please visit http:/www.vandapharma.com 57 investigational monoclonal antibody 57 midstage clinical 57 Presents Preclinical 57 pharmacogenomic translational research 57 riociguat 57 lintuzumab SGN 57 intravenous RSD# 57 metformin accumulation 57 cardiac myosin activator omecamtiv 57 phase IIb clinical 57 phase III isavuconazole 57 TRIOLEX HE# APOPTONE HE# 57 please visit http:/www.sunesis.com 57 prokinetic agent 57 PANVAC VF 57 Initiates Enrollment 57 Tech DVAX 57 commercialize ZYFLO CR 57 please visit www.lexpharma.com 57 nonclinical studies 57 VEGFR2 inhibitor 57 XL# XL# XL# XL# 57 Phase III LibiGel 57 GERD migraine headaches 57 HIV integrase inhibitors 57 apricitabine ATC 57 either acutely decompensated 57 markets Testim ® 57 CINTREDEKIN BESUDOTOX 57 Protexia ® 57 forodesine 57 Exelixis compounds 57 Inc. www.micromet inc.com 57 signal detection CTSD 57 TELINTRA 57 Zemiva TM 57 Merck OSI Pharmaceuticals 57 BRILINTA 57 HuMax TAC 57 severe hypercholesterolemia 57 Naglazyme R 57 Kosan dependence 57 CD# CEA 57 oncolytic virus therapies 56 Thalomid ® 56 forodesine hydrochloride 56 CIP TRAMADOL ER 56 EVIZON TM squalamine lactate 56 GTC recombinant human 56 R Saizen R 56 candidate SILENOR TM 56 phase IIb trial 56 kidney urologic 56 Aganocide TM 56 visit www.genmab.com 56 trastuzumab DM1 T DM1 56 novel VDA molecule 56 Proellex TM 56 S OMX GEN 56 Hematide ™ 56 hyperphenylalaninemia HPA due 56 squalamine 56 Bioaccelerate compounds under 56 Severe hypersensitivity reactions 56 SAR# [002] 56 Boehringer Ingelheim MedImmune 56 Cytogen marketed 56 DPX Survivac 56 ELADUR ™ 56 Zemplar Capsules 56 MAb therapy 56 im peramivir 56 EVIZON TM 56 Acapodene R 56 acetonide FA 56 Hematide ™ peginesatide 56 Reports Preclinical Data 56 Fast Track designations 56 Please visit www.antisoma.com 56 Auxilium anticipates 56 developing adecatumumab 56 CIP ISOTRETINOIN 56 Stimuvax R 56 Warner Chilcott Actonel 56 gastroenterology neurology 56 RSD# oral 56 TM pralatrexate injection 56 CoTherix logo 56 CORT # 56 product TNFerade TM 56 LEP ETU 56 ENABLE Phase 2 56 rxRNA 56 containing LABAs 56 IG HCR ;) CO 56 FOLOTYN ® 56 pipeline ImmunoGen collaborators 56 HepeX B TM 56 dyslipidemia hypertension diabetes 56 POSIDUR TM ELADUR TM 56 visit www.genenews.com 56 orally inhaled migraine 56 sanofi aventis Bayer Schering 56 investigational humanized monoclonal antibody 56 Budesonide foam crofelemer 55 R lenalidomide 55 GRALISE 55 Tasimelteon 55 gastrointestinal mucositis 55 Pruvel ™ prulifloxacin 55 RAPTIVA 55 lomitapide 55 urocortin 2 55 Genasense evaluating 55 XOMA 3AB 55 R MSCRAMM 55 hypoxia activated prodrug 55 VP# [004] 55 ThermoDox ® clinical 55 MCSP respectively 55 vernakalant oral 55 bone marrow reticulin deposition 55 Cephalon GlaxoSmithKline 55 Rhucin ® recombinant 55 R sorafenib tablets 55 visit www.sciclone.com 55 Cleviprex TM clevidipine 55 catheter occlusion 55 immunotherapeutic approaches 55 NicVAX TM 55 GlaxoSmithKline Genentech 55 SILENOR TM doxepin HCl 55 HGS ETR2 55 alvespimycin 55 pentadentate logo R 55 constipation OIC 55 please visit www.middlebrookpharma.com 55 postapproval 55 TranSwitch indebtedness 55 candidates Azedra TM 55 midstage trials 55 initiate Phase 1b 55 Phase 2a clinical trials 55 Merck Serono Nycomed 55 sodium thiosulfate STS 55 gastrointestinal disorders ATI 55 Shigamabs ® 55 product platforms AZX# 55 MyVax R 55 Fibrillex TM 55 BEMA ® 55 please visit www.advaxis.com 55 Asentar TM 55 CholeraGarde R Peru 55 Inc EXEL 55 ADL# novel 55 successfully commercialize Iluvien 55 Other ImmunoGen collaborative 55 HuCAL antibodies 55 severe dermatologic toxicities 55 PRN FDA Approves 55 website www.depomedinc.com 55 LNP formulations 55 Dementia Related Psychosis 55 TP# CETi 1 55 AQUAVAN R 55 please visit www.medicinova.com 55 LEVAQUIN ® 55 TRANSDUR ® 55 Azedra TM Onalta TM 55 iii GTx 55 novel emulsion formulation 55 website www.depomed.com 55 CRMD# 55 company website www.novavax.com 55 ospemifene 55 Mesafem 55 Enrolls First 55 Nasdaq CLDX 54 thrombin component 54 Zemiva ™ 54 Poly ICLC 54 candidate TNFerade biologic 54 Phase Ib clinical trials 54 Behcet uveitis 54 doxepin HCl 54 HYVISC R 54 Ostarine TM 54 receiving XGEVA 54 include ClindaReach TM 54 panitumumab Vectibix 54 FACTIVE R gemifloxacin 54 dermatitis acneiform pruritus erythema 54 Zemiva TM Trofex TM 54 dextromethorphan quinidine 54 dirucotide MBP# 54 aplindore 54 brand ciclesonide HFA 54 TM Aganocide 54 SinuNase TM 54 Gamunex C 54 pulls Darvon painkiller 54 BLA submission 54 SILENOR TM 54 zileuton CR 54 SILENOR ™ 54 vascular occlusive diseases 54 ELADUR 54 ERBITUX dermatologic toxicities 54 recurrent metastatic ovarian cancer 54 TOCOSOL Paclitaxel 54 TYGACIL 54 Amoxicillin PULSYS Phase III 54 hypercholesterolemic patients 54 ALN HPN 54 evaluating bafetinib 54 omecamtiv mecarbil 54 anthracycline taxane 54 Act PDUFA date 54 LymphoStat B belimumab 54 Loramyc ™ 54 visilizumab 54 molecular chaperone regulation 54 Nasdaq CYCC Nasdaq CYCCP 54 dirucotide 54 REGN# 54 UVIDEM 54 Adnectin 54 treat dysmenorrhea 54 Ecallantide 54 staphylococcal vaccine 54 Earns Milestone Payment 54 vitreoretinal disorders 54 Inc. NASDAQ ICGN 54 Submits IND 54 severe hypersensitivity reactions 54 diarrhea headache nausea 54 postoperative ileus POI 54 AIMM trial 54 REMOXY R 54 patients coinfected 54 alfimeprase direct 54 Bristol Myers Squibb Celgene 54 novel therapeutic antibodies 54 Receives Milestone Payment 54 dacetuzumab collaboration 54 Initiates Clinical 53 Veronate R 53 Dyax phage display 53 Receives Fast Track 53 cinacalcet HCl 53 http:/www.optimerpharma.com 53 OvaRex ® MAb 53 NEUPOGEN 53 Vitrasert ® 53 GSK# [002] 53 Hiberix 53 Selzentry Celsentri 53 humanized therapeutic 53 Amigal TM 53 Panflu TM 53 ZEGERID Chewable Tablets 53 menopause contraception 53 website http:/www.sinovac.com 53 Genentech sanofi aventis 53 endometriosis ovarian cysts 53 Actilon 53 Proquin XR 53 palonosetron hydrochloride injection 53 deforolimus 53 oral taxane 53 timelines communicated 53 REVIVE Diabetes 53 Sulonex TM 53 testing huN# DM1 53 PER.C6 r 53 areas neurology gastrointestinal 53 IL# PE#QQR 53 Stedivaze 53 arsenic trioxide injection 53 PRIMO CABG2 53 biotherapeutic drugs 53 MULTAQ 53 FUSILEV ® 53 Gammagard Liquid 53 oral PTH technology 53 Somatuline R Depot 53 ACAPODENE R 53 HepeX B 53 ACAPODENE TM 53 MEK Inhibitor 53 website www.novavax.com 53 http:/www.tripos.com 53 prodrug TH 53 pharmacodynamic markers 53 subsidiaries visit http:/www.apricusbio.com 53 myocardial infarction ventricular fibrillation 53 TransVax TM 53 TASE EVGN.TA 53 systemic immunosuppressive drugs 53 GSK # 53 proprietary Capillary Aerosolization Technology 53 Submits Supplemental 53 Squibb Genentech 53 myelofibrosis polycythemia vera 53 ATPace TM 53 Biogen Genentech 53 clinical trials SGN 53 Panzem R 53 NEUMUNE 53 SAR# [004] 53 Triapine R 53 Neurogen disclaims 53 Inc. NASDAQ ZLCS 53 Shigamabs R 53 diabetes sciatica 53 Applehead I. 53 investigational hepatitis B 53 indiplon capsules 53 Therapeutic Competitors Companies 53 IMiDs 53 Phenoptin 53 NEBIDO R 53 targeted anticancer biopharmaceuticals 53 Hepatocellular Carcinoma HCC 53 AzaSite Xtra 53 Co BMY BMY 53 commercialize NicVAX 53 Fibrosis Foundation Therapeutics 53 developing Surfactant Replacement 53 Puricase PEG uricase 53 myeloproliferative diseases 53 TRAIL receptor antibody mapatumumab 53 H#N# VLP 53 disease CDAD 53 number NCT# ClinicalTrials.gov 53 ragweed allergy immunotherapeutic 53 Cardium Therapeutics TM 53 serum phosphorous 53 Myelodysplastic syndromes MDS 53 ENRICH trial 53 modified glutathione analog 53 non alcoholic steatohepatitis 53 MSCRAMM ® 53 clinical trials dacetuzumab SGN 53 TRANSDUR ™ 53 Entereg TM 53 TOCOSOL Camptothecin 53 BUPHENYL 53 prolong QT interval 53 PRECISE Trial 53 Progenta TM 52 JAK2 Inhibitor 52 dihydrochloride Tablets 52 Cariprazine 52 Triolex 52 Q#IR 52 http:/www.nastech.com 52 Symphony tCGM 52 proprietary radiolabeled monoclonal 52 fund BioSante LibiGel 52 exocrine pancreatic insufficiency 52 #D#C# 52 www.telik.com 52 sNDAs 52 MethyPatch 52 Phase IIb clinical trials 52 herpes zoster shingles 52 highly purified pasteurized 52 Initiates Phase 2b 52 Genentech Wyeth Pharmaceuticals 52 diabetes irritable bowel 52 proprietary intravenous formulation 52 R rilonacept Injection 52 therapeutic monoclonal antibody 52 dopaminergic therapy 52 trivalent influenza vaccine 52 Telintra 52 refractory chronic lymphocytic 52 antiplatelet medications 52 including acne photodamage 52 Genentech Boehringer Ingelheim 52 refractory gout 52 inhalant addiction 52 CapMed Patient Portal 52 cladribine Cladribine Tablets 52 Inc AMGN AMGN 52 vii Cubist ability 52 neuropathic pain spasticity 52 CIMZIA ® 52 Nicotine Conjugate Vaccine 52 2 inhibitor CYT# 52 Metabasis dependence 52 ocular formulation 52 pelvic malignancies 52 Gel repository corticotropin injection 52 rheumatoid arthritis thrombocytopenia 52 Receive Milestone Payment 52 serious cardiovascular thrombotic 52 diagnostic molecular imaging 52 Trofex ™ 52 KAPVAY ™ 52 oral calcitonin licensed 52 talactoferrin 52 ruxolitinib 52 concerning Wowjoint 52 PURPOSE OF SAFE HARBOR 52 Corporation GENZ 52 treat chronic sinusitis 52 evaluating intravenous picoplatin 52 assigned PDUFA 52 HGS ETR1 mapatumumab 52 Reveals Positive 52 tramiprosate Alzhemed TM 52 beta blockers ACE inhibitors 52 oncology metabolic disorders 52 coronary stent merged 52 R ferumoxytol Injection 52 Vaxfectin R 52 Omigard 52 AcryMed technologies 52 TYZEKA 52 BiovaxID TM 52 Luveris R Ovidrel R 52 REMOXY ® 52 visit www.noven.com 52 Alseres Cethrin 52 DCVax R Prostate 52 clinical pharmacology studies 52 PEGylated docetaxel 52 JNJ Q2 52 Topical Interferon Alpha 2b 52 Provectus Pharmaceuticals specializes 52 Dynepo TM 52 development diagnostics combinatorial 52 mocetinostat MGCD# 52 Syndax Pharmaceuticals Inc. 52 HepaGam B 52 Licenses Novel 52 Presents Positive Preclinical 52 velafermin 52 Entocort 52 CTAP# Capsules 52 granted Ortec 52 XL# XL# XL# 52 candidate AQ4N 52 receiving TNF blockers 52 histrelin manufacturing marketing 52 revaccinate according 52 adrenergic regulation 52 ™ testosterone gel 52 calcitonin manufacturing 52 DOS# 52 pediatric exclusivity 52 Nasdaq DVAX 52 manufactures minimally invasive 52 Lamictal ODT 52 Corporation GENZ GENZ 52 headache abdominal pain 52 APTIVUS ritonavir 52 dacetuzumab 52 Idenix anticipates 52 Urocidin TM 52 Azedra ™ 52 multicenter Phase III 52 allosteric modulator PAM 52 Somatuline Depot 52 Thalomid R 51 induced mucositis 51 R metformin Concor 51 Tß4 51 Perforomist TM formoterol fumarate 51 AVAX AC Vaccine 51 molecular therapeutics immunotherapies 51 candidate Zemiva TM 51 transthyretin mediated amyloidosis ATTR 51 IL# PE 51 fibrosis oncology 51 using BioSante patented 51 liver resection surgeries 51 faropenem 51 Tripos logo 51 Announces Tentative Approval 51 TORISEL 51 Bicifadine 51 rheumatoid arthritis osteoarthritis ankylosing 51 periodically reassessed 51 #/#/# Cytokinetics Incorporated 51 hypersensitivity allergic reactions 51 cancer neurology ophthalmology 51 Milestone Payment From 51 acute peptic ulcer 51 ORENCIA R 51 synthetic retinoid 51 celgosivir 51 Gets FDA Clearance 51 5 HT2A inverse 51 Phase IIa trials 51 Takeda Kyowa Hakko Kirin 51 AGILECT R 51 please visit www.chiron.com 51 ClindaReach ® 51 Phase IIa clinical trials 51 interferon beta 1a infertility 51 EMPOWER pivotal trial 51 PMX # heptagonist 51 Twinrix 51 Through Glycoscience R 51 Silenor NDA 51 vivo toxicology 51 evaluating tivozanib 51 cMET inhibitor 51 visit biotech.com 51 PentaStaph 51 neutropenia thrombocytopenia 51 PAION AG ISIN 51 androgen receptor modulator 51 myopathy rhabdomyolysis 51 RhuDex TM 51 anaphylactic reactions bronchospasm 51 intravenous formulations 51 Tyzeka Sebivo 51 LentiVector technology 51 LymphoStat B Phase 51 OctoPlus licensed 51 Cephalon GlaxoSmithKline Organon 51 Additionally Soligenix 51 R bisoprolol Euthyrox 51 Inc NVAX 51 therapeutic mAbs 51 Pruvel TM prulifloxacin 51 cystic fibrosis chronic pancreatitis 51 Planetwide Media My 51 including BOXED WARNINGS 51 outlicensing 51 SNALP technology 51 Includes KCI proprietary 51 www.medicago.com 51 chemistry microbiology immunology 51 equine osteoarthritis marketed 51 endothelin antagonists 51 Prodarsan ® 51 Synerx 51 CytoCore Solutions System 51 syndrome overactive bladder 51 Trovax 51 FOLFOX6 chemotherapy regimen 51 EHT AGN 51 Hill Rom enhancing 51 alvimopan Investigational 51 Exelixis logo 51 SPRYCEL ® 51 known sulfonamide allergy 51 lesinurad 51 6 sulfatase 51 Fentanyl TAIFUN R 51 Onalta ™ 51 HEPLISAV TM 51 Anturol TM 51 encapsulates siRNAs 51 vosaroxin 51 Web Site http:/www.cryolife.com 51 factor VIIa 51 lenalidomide Revlimid R 51 visit www.regenbio.com 51 IV APAP 51 MSCRAMM R 51 Hereafter Inception Iron Man 51 alvimopan 51 HGS ETR1 51 NASDAQ ENMD 51 LPM TM 51 Acetavance TM 51 SCIB1 51 NNR Therapeutics 51 www.pharmion.com 51 JAK2 inhibitor 51 GATTEX ™ 51 commercialize CorMedix drug 51 PREOS R 51 Nasdaq ABII 51 Phase #/#a 51 BLA filing 51 Isis Alnylam 51 SIRT1 activators 51 Arranon 51 ROTATEQ 51 injectable influenza 51 moderate hepatic impairment 51 tiagabine 51 commercialize Intermezzo R 51 www.aastrom.com 51 Locteron exclusively 51 dexanabinol 51 APTIVUS r 51 clinical pharmacology clinical trials 51 GALNS N acetylgalactosamine 51 takes ethosuximide 51 methylnaltrexone 51 Inc. Nasdaq SLXA 51 LE SN# 51 Aurora kinase inhibitor 51 cathepsin K inhibitor 51 YOUR LOCAL ANIMAL SHELTER 51 proprietary capillary aerosolization 51 hypereosinophilic syndrome 51 worsening thrombocytopenia 51 eprodisate KIACTA TM 51 endothelin receptor antagonists 51 palonosetron hydrochloride Injection Dacogen 51 Marketing Authorisation 51 glucokinase activator 51 candidate custirsen 51 delay bone metastases 51 S NVO NVO 51 TRAIL receptor antibody 51 website www.nyandcompany.com 51 TRISENOX ® 51 Progenics Daiichi Sankyo 51 damage cirrhosis liver 51 EGRIFTA TM 51 thorough QT 51 Cintredekin Besudotox 51 Company website www.anormed.com 51 Milestone Payment 51 oral flupirtine 51 nonhematologic adverse reactions 51 midstage studies 51 Pausch blogged regularly 51 UPLYSO 51 generation DACH Platinum 51 ChronVac C 50 Sanvar R 50 orBec ® oral beclomethasone 50 GPR# agonist 50 novel proprietary KL4 50 gemifloxacin 50 ALTROPANE R 50 carcinoid syndrome 50 erlotinib Tarceva ® 50 SearchHelp communications 50 banned Darvon Darvocet 50 trivalent seasonal influenza 50 elevated creatine phosphokinase 50 Erythropoietic therapies may 50 AGGRASTAT ® tirofiban hydrochloride 50 visit www.antisoma.com 50 Anturol ® 50 NeurogesX Nasdaq NGSX 50 candidate MyVax 50 PROSTASCINT R 50 ENL recurrence 50 clinical trials lintuzumab SGN 50 Daytrana TM 50 AQ4N 50 GVAX R 50 Cellegesic 50 Dacogen injection 50 Pharmos pipeline 50 adenovirus serotype 50 REVLIMID lenalidomide 50 neutropenia dehydration dyspnea 50 promotes MERREM ® 50 InPath TM System 50 motesanib 50 Potelligent Technology 50 Prestara 50 Lymphoseek ® 50 iii Cubist 50 Nasdaq VRTX 50 6R BH4 50 Inc. Nasdaq MITI 50 please visit http:/www.avastin.com 50 designated Restanza 50 Exherin TM 50 Hyundai Kia Renault Nissan 50 2 methoxyestradiol 50 HIV treatments Reyataz 50 HCl PEPCID ® famotidine 50 BioGlue R 50 Inc. NASDAQ TRMS 50 THE INABILITY TO 50 Icatibant 50 ribavirin therapy 50 Shire Attention Deficit 50 PEG PAL 50 infectious diseases autoimmune diseases 50 Pharmos proprietary 50 TLR9 agonists 50 Regulus Alnylam 50 International LAB Pharma 50 Amgen Bayer Schering 50 treating psychiatric disorders 50 Solazed ™ 50 drug Galvus Sanofi 50 Associated Press Writers Jorde 50 Postherpetic neuralgia PHN 50 Pain Neutralizer holds 50 REBETOL combination therapy 50 MolecularBreeding 50 nitric oxide donating prostaglandin 50 Boehringer Ingelheim CHDI Novartis 50 MDS MPD 50 LibiGel Phase III 50 MGCD# MGCD# [001] 50 capromab pendetide kit 50 antineoplastic 50 nonvaccine 50 TRISENOX R 50 VERTEX PHARMACEUTICALS 50 sumatriptan succinate 50 neurology cardiology 50 Nevada Casino Aztar 50 immunotherapies 2A/Furin 50 obj obj = 50 topical hemostat 50 phosphorylase PNP inhibitor 50 tizanidine hydrochloride short 50 Protexia R 50 nephropathic cystinosis cystinosis 50 baminercept 50 InterfeRx 50 viii insufficient 50 Nanobody ® 50 R Nestle Crunch 50 Generx TM 50 AMPAKINE CX# 50 VIOXX Lawsuits 50 Roche SWX ROG 50 GLP toxicology studies 50 daptomycin 50 INVEGA ® 50 naloxol derivative 50 ENZON 50 BioSante licensees 50 Novartis Organon 50 including immunology pulmonology 50 http:/www.palatin.com 50 SARMs 50 Immunotherapeutic 50 Product Characteristics 50 TMC# [002] 50 ESPN ESPNEWS ESPN 50 enhanced skin permeation 50 d l leucovorin 50 Therapies SRT 50 Lauriad ® 50 oncology dermatology 50 bar Twizzlers KitKat 50 Shire BioChem Inc. 50 ASAQ combines 50 DepoCyt 50 drilling recompletions 50 alpha interferons 50 visit www.intellon.com 50 HuCAL GOLD R 50 Asentar ™ 50 mark eOn 50 include Biosite Medarex 50 DITPA 49 psychiatry pediatrics 49 Gralise 49 Dacetuzumab 49 AcryMed Incorporated 49 bafetinib 49 RAPTIVA r 49 Investigational Device Exemption 49 skin itched 49 VaxImmune 49 SparVax ™ 49 Reports Inducement Grants 49 peptide compounds 49 SYMMETRY trial 49 TriPath Oncology 49 Homspera TM 49 visit www.PAREXEL.com 49 bazedoxifene conjugated estrogens 49 FavId 49 Trigger Relevant Expiry Required 49 Xoma Ltd 49 sorafenib tablets 49 include PLX IBD 49 Navelbine ® 49 monoamine oxidase inhibitors MAOIs 49 ophthalmology dermatology 49 Tibotec BVBA 49 SINA Annual Report 49 Eligard R 49 primary hypercholesterolemia 49 GeoVax AIDS vaccine 49 Allovectin 7 r 49 M Enoxaparin 49 neuroscience cardiology 49 inhaled glucocorticoids 49 Muscle relaxants 49 Emily Blunt shimmered 49 Ferlay J et al 49 r hGH 49 Corp EPCT 49 NovaBay Aganocide compounds 49 sarcoma melanoma 49 oseltamivir Tamiflu ® 49 AGGRASTAT R tirofiban hydrochloride 49 Biologic License Application BLA 49 hyperphosphorylation 49 PDX pralatrexate 49 Juicy Couture Ralph Lauren 49 Tissue Repair TM 49 preclinical compounds 49 commercialize Aganocides 49 NYSE FRX longstanding 49 Rotarix R 49 TELCYTA 49 CB2 selective 49 Inc. NASDAQ CRTX 49 COU AA 49 APTIMA HPV assay 49 migraine headaches neuropathic pain 49 imaging neurodegenerative disorders 49 mesylate tablets fluoroquinolone antibiotic 49 GlaxoSmithKline Amgen 49 Orapred ODT 49 developing KL4 surfactant 49 GlaxoSmithKline Amgen Cystic 49 research anddevelopment 49 concerning Xanthus 49 Peyronie disease Frozen Shoulder 49 validating biomarkers 49 B Anflu R 49 Cloretazine ® 49 www.vioquestpharm.com 49 KIDS FINANCIAL SKILLS 49 Aurograb 49 pafuramidine 49 Oracea ® 49 five MDS subtypes 49 Ramoplanin 49 Zeneus 49 specifically hypoactive sexual 49 OTC ZEGERID 49 Services #:#-#,# Abstract 49 corticotropin injection 49 peramivir clinical trials 49 bevirimat clinical 49 REGIONAL THEATER TONY AWARD 49 dacetuzumab SGN 49 Gemzar ® 49 Dr. Assa Amit 49 Shigamabs 49 oral NSAIDs 49 pyrexia mucositis sepsis febrile 49 immunological disorders 49 Paris IPN Euronext 49 ISTA Pharmaceuticals Announces 49 Mali Mauritius Mozambique 49 Medscape MedicineNet RxList theheart.org 49 commercializing Loramyc ® 49 Alnylam Biotherapeutics 49 Somatuline R Autogel R 49 proprietary phage display 49 authority Gurian Sherman 49 Irinotecan Hydrochloride Injection 49 aesthetics urologic specialties 49 Increlex TM 49 Exelbine 49 LX# LX# LX# 49 Hedgehog agonist 49 Genentech Bayer CuraGen 49 VDAs 49 Phase #b/#a 49 anti CD3 monoclonal 49 ACTILON 49 candor Carrie Rickey 49 endocrinology gastroenterology 49 CTA# Injection 49 CONBRIZA 49 PROVISIONS OF THE PRIVATE 49 PXD# 49 Invasive fungal infections 49 VYVANSE TM lisdexamfetamine 49 www.adeonapharma.com 49 reactive airways disease 49 DAILY LARIAT ONE 49 Syntonix 49 Linjeta TM 49 Premature menopause 49 Subpart E 49 Inc. NASDAQ ONTY 49 Known hypersensitivity 49 Katherine Heigl Mariska Hargitay 49 Hepatitis C HCV 49 Shire plc Attention Deficit 49 JUVISTA 49 ZFP Therapeutics 49 accompanying electrolyte abnormalities 49 Gestiva TM 49 mapatumumab 49 ENOUGH TO BE 49 strong CYP#A# inducers 49 diarrhea fatigue asthenia 49 CB2 selective receptor agonist 49 www.cerus.com 49 biomimetics non 49 Zegerid OTC 49 Idec Roche 49 therapeutics diagnostics 49 PD2i ® algorithm 49 Sepracor anticipates 49 exclusive sublicense 49 GlaxoSmithKline Biologicals SA 49 Cloretazine 49 Excellarate TM 49 vismodegib 48 TOLAMBA 48 orthopedics urology 48 mucositis ProLindac ™ 48 PER.C6 ® production 48 Sands Macao Venetian Macau 48 Pharmacopeia Phase 48 adverse reactions occurring 48 gynecology paediatrics 48 Paramount Classics Insurge Pictures 48 serologically active systemic lupus 48 oncology neurology 48 PROBLEMS WITH THE 48 Soliris eculizumab 48 develop HBV reactivation 48 Risperidone Oral Solution 48 treating sarcoma lymphoma 48 skin exfoliation paronychia